Rafferty Asset Management, LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,618,971
-8.3%
45,323
+45.0%
0.04%
-4.9%
Q2 2023$7,220,136
+5.9%
31,256
+11.1%
0.04%
-10.9%
Q1 2023$6,815,985
-77.7%
28,135
-73.3%
0.05%
-82.0%
Q4 2022$30,589,448
+614.0%
105,390
+59.9%
0.26%
+456.5%
Q3 2022$4,284,000
+92.1%
65,921
+111.6%
0.05%
+119.0%
Q2 2022$2,230,000
-50.9%
31,160
-32.7%
0.02%
-22.2%
Q1 2022$4,542,000
+46.7%
46,287
+26.7%
0.03%
+68.8%
Q4 2021$3,097,000
+23.4%
36,547
+16.2%
0.02%
-5.9%
Q3 2021$2,510,000
+6.6%
31,456
+30.2%
0.02%
+13.3%
Q2 2021$2,354,000
-28.8%
24,165
-14.5%
0.02%
-34.8%
Q1 2021$3,307,000
+326.7%
28,275
+305.4%
0.02%
+187.5%
Q4 2020$775,000
-37.9%
6,974
-33.6%
0.01%
-46.7%
Q3 2020$1,247,000
+44.8%
10,506
+38.2%
0.02%
+25.0%
Q2 2020$861,000
-39.7%
7,603
-51.5%
0.01%
-45.5%
Q4 2019$1,429,000
-51.6%
15,679
-54.2%
0.02%
-52.2%
Q3 2019$2,951,000
-28.2%
34,230
-12.7%
0.05%
-36.1%
Q2 2019$4,111,000
+4.2%
39,219
+24.5%
0.07%
+12.5%
Q1 2019$3,947,00031,5110.06%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HealthCor Management, L.P. 902,601$100,342,0003.87%
L1 Capital Pty Ltd 113,464$12,608,0002.35%
Avoro Capital Advisors LLC 1,225,000$136,183,0002.34%
Tao Capital Management LP 51,396$5,714,0001.40%
ARMISTICE CAPITAL, LLC 316,000$35,130,0001.20%
ACUTA CAPITAL PARTNERS, LLC 32,500$3,613,0000.98%
Capital Impact Advisors, LLC 24,351$2,707,0000.66%
Baker Brothers Advisors 1,499,213$166,668,0000.63%
Rock Springs Capital Management LP 256,768$28,545,0000.60%
SHIKIAR ASSET MANAGEMENT INC 12,000$1,334,0000.48%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders